[ Skip to Main Content ]
COVID-19: How We’re Responding

Our Work

Evidence-based #SelfCare can support governments to achieve #UHC.

Join @PATHtweets @EngenderHealth & @SFHNigeria for “Self-Care & UHC: How self-care can help leave no one behind,” moderated by our #SRHR Director @MalayahHa.

Series & session registration: http://bit.ly/SelfCare-UHC

Yes, and resilient #healthsystems need oxygen & other surgery-related supplies and devices. Surgical systems strengthening = health systems strengthening. #SurgeryUHC @PATHtweets @theG4Alliance @HarvardPGSSC @Mattt_Hey @EngenderHealth #globalsurgery https://twitter.com/theGFF/status/1421164976249712641

Am proud to have been nominated by @AYTTanzania 2021 awards as an Outstanding Youth in SDGs, and my project Her Story Our Action funded by @WomenDeliver through @YouthDeliver, hosted by @EngenderHealth as a leading youth program of the year. Please vote for me through below link

There are so many links between #SRHR and #EducationForAll, including the critical need to end #FGM. Thank you @DominicRaab and Raychelle Omamo for this important piece. @EngenderHealth @OrchidProject https://twitter.com/grethepetersen/status/1420868613901361152

Tous les jeunes devraient pouvoir poursuivre la carrière de leur choix! Voici quelques femmes inspirantes qui travaillent avec l’équipe de EngenderHealth au Burkina Faso pour éliminer les obstacles liés au genre dans leurs professions. 🙌👏

To reach #UHC2030, we need every idea on the table for transforming health systems and markets to advance people-centered primary health care—including #selfcare! Join @FinancingAllian
@PATHtweets @EngenderHealth & @SFHNigeria to learn more on 3 Aug! https://discoverselfcare.community.tc/t/2021/events/self-care-and-uhc-how-self-care-can-help-leave-no-one-behind-rwe9s8x3s9m1Pno9QcDUa8

On August 3, join @EngenderHealth, @SFHNigeria, and @PATHtweets for "Self-Care and UHC: How Self-Care Can Help Leave No One Behind."

Register for the Self Care Learning and Discovery Series to attend the webinar! ➡️ http://discoverselfcare.community.tc/

To reach #UHC2030, we need every idea on the table for transforming health systems and markets to advance people-centered primary health care—including #selfcare. Join @PATHtweets @EngenderHealth & @SFHNigeria to learn more on 3 Aug!➡️https://discoverselfcare.community.tc/t/2021/events/self-care-and-uhc-how-self-care-can-help-leave-no-one-behind-rwe9s8x3s9m1Pno9QcDUa8

Congratulations, @JSIhealth, @WorldEd, and @MargaretCrotty! We at @EngenderHealth appreciate our partnerships to date and look forward to more, as we engage on #health and #education, and the intersection of the two. https://twitter.com/JSIhealth/status/1420443988285399040

Join us for the @EngenderHealth + @CHOICEforYouth webinar on meaningful youth participation on Aug 11th! Register here: https://engenderhealth.zoom.us/meeting/register/tZckd-mvqT8rG9E9kYXghEAvBs0bc2XrlCPp #AYSRHR

Load More...

Eclampsia and Pre-Eclampsia

Giving birth should be a time for celebration, but for more than half a million women each year—one every 90 seconds—pregnancy and childbirth end in death and mourning. Ninety-nine percent of these deaths occur in developing countries, and nearly all are preventable.

One of the leading causes of maternal death is pre-eclampsia—the rapid elevation of blood pressure during pregnancy—which, if untreated, can lead to seizures (eclampsia), kidney and liver damage, and ultimately, death. Eclampsia and severe pre-eclampsia claim the lives of an estimated 63,000 women each year, as well as the lives of many of their babies.  

A Ready Solution
The World Health Organization recognizes and recommends injectable magnesium sulfate—also known as Epsom salts—as the safest, most effective, and lowest-cost medication for treating pre-eclampsia and eclampsia. Magnesium sulfate is the standard treatment for these conditions in the developed world and has been for 20 years. Less-effective and riskier medications (such as diazepam and phenytoin), however, are still widely used in developing countries—if any treatment is available at all.

 

OUR COMMITMENT
We commit to reducing maternal mortality with magnesium sulfate in India, Mexico, and Nigeria. Through training, advocacy, and education, we will increase access to the lifesaving treatment for pre-eclampsia and eclampsia, leading causes of maternal mortality.

 

 

Clinton Global Initiative Commitment
This disparity must end. EngenderHealth, the University of Oxford, and the John D. & Catherine T. MacArthur Foundation are making a joint commitment as part of the Clinton Global Initiative to expand access to magnesium sulfate by:

  • Training health professionals through web-based interactive programs on when and how to administer magnesium sulfate
  • Advocating for magnesium sulfate to be part of every developing country’s list of essential drugs
  • Helping develop and/or reinforce national protocols mandating magnesium sulfate as the preferred treatment for pre-eclampsia and eclampsia
  • Ensuring the availability of magnesium sulfate in hospitals

Call to Action
In 2007, EngenderHealth and the University of Oxford brought together leading scientists, advocates, researchers, and representatives of the WHO, UNICEF, United Nations agencies, and national ministries of health from around the world to identify barriers to the availability and use of magnesium sulfate to treat pre-eclampsia and eclampsia. This historic gathering of global public health experts identified the primary barriers to be a lack of national guidelines, a shortage of educated and trained health care professionals, and scarce supplies of magnesium sulfate.

Based on these conclusions, EngenderHealth and the University of Oxford developed a “Call to Action” and report that called on policy makers and ministers of health to make pre-eclampsia and eclampsia a higher priority and to set national guidelines for treatment and care based on WHO guidelines. Decision makers and international and national health organizations and agencies were also urged to help make magnesium sulfate more available and affordable.

The full report, Balancing the Scales: Expanding Treatment for Pregnant Women with Life-Threatening Hypertensive Conditions in Developing Countries, is available for download (PDF, 316KB), as is the International Call to Action (PDF, 27KB).

Share this page: